PNV

1.57%

$2.58 polynovo limited

Ann: PolyNovo presents at Macquarie Australia Conference, page-53

First 53 Last

Share
Profile

Follow
BPAA

4,237 Posts.

792

05/05/23

11:59

Post #: 67624800
Share

Originally posted by Hapman: ↑

Then you’ll probably be missing quite a few millions for not understanding your investment in pharmaceutical/medical shares.
Why is the SP being so heavily punished? Simple fact is growth hasn’t met market expectations. Why is this important is the simple fact that BTM/MTX only enjoy a very limited patented window. PNV needs to grow and establish its branding and product as fast as possible. Every quarter/month that it does not achieve such aggressive growth means we are closer and closer to when cheap Chinese/Indian generics will enter and/or large pharmaceuticals will enter with their massive deep pockets, large marketing and sales force and channels to disrupt a minnow like PNV. Essentially, the margin that you guys chirp about will shrink.
So unless PNV can quickly establishes itself as market leader, build up a large cash kitty (patent period) to be able to defend its market share.
sorry to burst your dreams but this is a tough tough market to be in and you either become the big fish or you get swallowed whole (Take over) or kicked out (lose market share and leave).
I believe my growth target is valid is more than fair. 60+%coming from existing staff (18mths+ service and based on Ed comment that 4 customer per sales to be driven up to 10+ and cross department reach within same hospital) and 20-50% from new staff added (6-18 mths service and gave them some discount based on some of the new hires might be only 6 mths into their jobs).
To simply look at the 50% growth and be satisfied is ignoring that PNV have had lots more foot solders on the ground to aid our course and organic sales growth from existing soldiers. No offence to kick’s model but maybe it needs to be updated to reflect that the company is a lot larger and it’s target needs to reflect this fact.

Expand

Writing a lot and hypothesizing doesn't make any of what you say correct. It probably feels good but its so far off anything logical

There is nothing to support what you're saying apart from your opinion

PNV Price at posting: $1.50 Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

MKG

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

NAM

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

MM8

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

MLS

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

ENV

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

ASN

Utah authorities sign off on Anson's lithium extraction plans at Green River

AZY

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

VUL

Vulcan appoints investment bank and M&A veteran to board

There are more pages in this discussion • 35 more messages in this thread...

First 53 Last

Add PNV (ASX) to my watchlist

(20min delay)
Last $2.58		Change 0.040(1.57%)		Mkt cap ! $1.781B

Open	High	Low	Value	Volume
$2.56	$2.59	$2.53	$3.881M	1.517M

Buyers (Bids)

No.	Vol.	Price($)
2	10150	$2.57

Sellers (Offers)

Price($)	Vol.	No.
$2.58	38947	2

View Market Depth

No.	Vol.	Price($)
1	2299	2.560
1	2299	2.550
1	2299	2.540
1	2299	2.530
3	2504	2.520

Price($)	Vol.	No.
2.580	38947	2
2.590	15790	2
2.600	51518	11
2.610	23573	2
2.620	5063	2

Last trade - 16.10pm 13/09/2024 (20 minute delay)

PNV (ASX) Chart

Ann: PolyNovo presents at Macquarie Australia Conference, page-53

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

Utah authorities sign off on Anson's lithium extraction plans at Green River

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

Vulcan appoints investment bank and M&A veteran to board

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: PolyNovo presents at Macquarie Australia Conference, page-53

Top Stories

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

Utah authorities sign off on Anson's lithium extraction plans at Green River

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

Vulcan appoints investment bank and M&A veteran to board

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News